Narasimhan Rajaram retweeted
Replying to @NIH
@NIH has awarded the Arkansas Integrative Metabolic Research Center $11.2 in Phase 2 funding, validating its great work to date. @AIMRC @UofA_Research @uacoehp @uarkfulbright @UofA_Engr @bumperscollege
news.uark.edu/articles/82685…
Narasimhan Rajaram retweeted
The M3R lab has moved to @Mizzou. Joining the great folks in NextGen Precision Health. Appreciative to @uacoehp for the opportunity and support getting the lab off the ground. We’re excited for the next chapter! #myotwitter
Narasimhan Rajaram retweeted
Righhht... now look up cost of college. Then figure out who's actually paying. If you're being honest with yourself you'll know by now that state pays there vs students here. Now, and here's what will blow your mind, figure out who gets exactly the grading system they want?
Narasimhan Rajaram retweeted
Are you searching for an end-to-end GUI to analyze single-cell data from fluorescence lifetime imaging microscopy (FLIM)? Wenxuan Zhao, @rupsa Datta, and Kayvan Samimi made FLIM Playground for you!
biorxiv.org/content/10.1101/…
github.com/skalalab/flim_pla…
allanware.quarto.pub/flim-pl… (1/2)
Narasimhan Rajaram retweeted
Supporting Fairness and Originality in NIH Research Applications grants.nih.gov/grants/guide/…
Narasimhan Rajaram retweeted
NIH will only accept six applications per PI per calendar year. drugmonkey.wordpress.com/202… via @drugmonkeyblog
Narasimhan Rajaram retweeted
AIM-HIGH trial published in Lancet
Molecular high-risk stage IA-IIA NSCLC as determined by 14-gene assay with improved survival with adjuvant chemo.
It is not often we see survival curves like this in early stage lung cancer.
thelancet.com/journals/lanre…
Narasimhan Rajaram retweeted
Congrats to Kevin Murach on receiving an Independent Investigator Award from the NIH! @UArkansas @KevinMurachPhD @uacoehp @NIH @U_AResearch #UARK
news.uark.edu/articles/78668…
Narasimhan Rajaram retweeted
Notice of Short-Term Extension to Early-Stage Investigator (ESI) Eligibility Period grants.nih.gov/grants/guide/…
Narasimhan Rajaram retweeted
Beyond excited to share my big @StJude news! We’re going to build an amazing hub for imaging technology development and deployment - driven by St Jude’s mission to transform the way the world understands and treats pediatric catastrophic diseases. Imaging innovators come join us!
St. Jude welcomes @HillmanLab as the founding chair of the new Department of Imaging Sciences. Her team will develop innovative tools to accelerate discovery and improve patient care. ow.ly/GZQG50UL653
Narasimhan Rajaram retweeted
#NIHHighRisk New Innovator Awardee Dr. Marius Nagalo is the first @uamshealth investigator to receive this award for his research using the VSV virus to treat #PancreaticCancer news.uams.edu/2024/10/08/mar…
Narasimhan Rajaram retweeted
Congratulations @KayvanSamimi for his newest paper: "Autofluorescence lifetime flow cytometry with time-correlated single photon counting." He resolves free and protein-bound NAD(P)H to discriminate metabolic subsets of cells with high throughput
onlinelibrary.wiley.com/doi/…
Narasimhan Rajaram retweeted
All @NIH funded and relevant researchers NEED to study this NIH restructuring proposal from the US #Congress. Huge implications! Comment period is critical to provide input. I will. E.g., @NIBIBgov goes away or folded into others - but IMHO too many overlaps.
A new congressional blueprint for restructuring the NIH has been released. It proposes consolidating NIH's 27 IC's and centers into 15 categories, plus term limits for directors. It adds a national security review to grant apps. Public comments due Aug. 16 energycommerce.house.gov/pos…
Narasimhan Rajaram retweeted
A smart nanoprobe developed by @JohnsHopkins researchers revealed elusive prostate tumors in animals in an NIBIB-supported study. Find out how: nibib.nih.gov/news-events/ne…
Narasimhan Rajaram retweeted
We're sad to hear of the passing of Joseph Izatt, one of the greatest mentors and engineers. He has been an example of kind excellence, and he made us all better 💔 optica.org/History/Biographi…
bme.duke.edu/faculty/joseph-…
Narasimhan Rajaram retweeted
Is forgetting a bug or a feature? Can you delay it and remember longer? Our 🥶COOLEST paper to date (and our most poetic abstract…) Show LOVE ❤️and please SHARE! Thread (1/N)👇
biorxiv.org/content/10.1101/…
Narasimhan Rajaram retweeted
Summary statements will be an overall impact paragraph (like now); there will be subheadings for Factors 1 - 3.
They will include clarifying reviewer comments under Factor 3 only if gaps related to the proposed research were identified.
For more info: go.nih.gov/SRF
Narasimhan Rajaram retweeted
Oh ho ho! NOT-OD-24-061 Marking changes in resubmissions no longer allowed (who was still doing that) - but a summary of substantial additions, deletions, and changes needs to be included the Introduction. Effective May 25th.




























